Paper35192545
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo AM and 29 others. J Clin Invest, 2022. Cited by 59 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. Papers, record 35192545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35192545
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| Female | |
| Fibroblasts | |
| Humans | |
| Mice | |
| Oncostatin M | |
| Signal Transduction |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 36169029 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | https://conductscience.org/library/papers/36169029 |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21975934 | c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M. | Cancer Res | 2011 | https://conductscience.org/library/papers/21975934 | PubMed |
| 2 | 24202395 | Microenvironmental regulation of tumor progression and metastasis. | Nat Med | 2013 | https://conductscience.org/library/papers/24202395 | PubMed |
| 3 | 22452939 | Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22452939 | PubMed |
| 4 | 31315034 | Inflammation and Cancer: Triggers, Mechanisms, and Consequences. | Immunity | 2019 | https://conductscience.org/library/papers/31315034 | PubMed |
| 5 | 29141660 | xCell: digitally portraying the tissue cellular heterogeneity landscape. | Genome Biol | 2017 | https://conductscience.org/library/papers/29141660 | PubMed |
| 6 | 22522925 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. | Nature | 2012 | https://conductscience.org/library/papers/22522925 | PubMed |
| 7 | 27725631 | Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. | Nat Commun | 2016 | https://conductscience.org/library/papers/27725631 | PubMed |
| 8 | 24659184 | Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. | J Pathol | 2014 | https://conductscience.org/library/papers/24659184 | PubMed |
| 9 | 25384214 | Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. | J Clin Invest | 2014 | https://conductscience.org/library/papers/25384214 | PubMed |
| 10 | 26667266 | Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. | Nat Commun | 2015 | https://conductscience.org/library/papers/26667266 | PubMed |
| 11 | 12460930 | A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. | Cancer Res | 2002 | https://conductscience.org/library/papers/12460930 | PubMed |
| 12 | 27339708 | The role of myeloid cells in cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27339708 | PubMed |
| 13 | 30995492 | Targeting Interleukin-6 Signaling in Clinic. | Immunity | 2019 | https://conductscience.org/library/papers/30995492 | PubMed |
| 14 | 12184808 | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. | Genome Biol | 2002 | https://conductscience.org/library/papers/12184808 | PubMed |
| 15 | 31402908 | Tuning the Tumor Myeloid Microenvironment to Fight Cancer. | Front Immunol | 2019 | https://conductscience.org/library/papers/31402908 | PubMed |
| 16 | 11257139 | Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. | J Exp Med | 2001 | https://conductscience.org/library/papers/11257139 | PubMed |
| 17 | 26000488 | Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. | Cell | 2015 | https://conductscience.org/library/papers/26000488 | PubMed |
| 18 | 22267707 | Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer. | Endocr Relat Cancer | 2012 | https://conductscience.org/library/papers/22267707 | PubMed |
| 19 | 31527531 | The Immune Microenvironment of Breast Cancer Progression. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31527531 | PubMed |
| 20 | 29900565 | In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody. | Br J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29900565 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42862350 | Inflammatory bowel disease and breast cancer: epidemiological evidence, shared biology, and clinical management. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42862350 | PubMed |
| 42746957 | Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues. | IUBMB Life | 2026 | https://conductscience.org/library/papers/42746957 | PubMed |
| 42303618 | Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression. | Nat Commun | 2026 | https://conductscience.org/library/papers/42303618 | PubMed |
| 42206145 | Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation. | Nat Mach Intell | 2026 | https://conductscience.org/library/papers/42206145 | PubMed |
| 41969272 | Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor Microenvironment. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41969272 | PubMed |
| 41863682 | Multi-omics profiling identifies ectopic olfactory receptors as putative drivers of tumor progression and prognostic indicators in clear cell renal cell carcinoma. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41863682 | PubMed |
| 41840689 | Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma. | BMC Med | 2026 | https://conductscience.org/library/papers/41840689 | PubMed |
| 41799521 | Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799521 | PubMed |
| 41372120 | Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41372120 | PubMed |
| 41366110 | Sema7a drives an immunosuppressive microenvironment of breast cancer via Kdm4a-mediated DNA replication regulation. | Commun Biol | 2025 | https://conductscience.org/library/papers/41366110 | PubMed |
| 41080785 | Transcriptomic analysis reveals the key role of inflammatory and immune signaling in the anti-perimenopausal depression effects of Bushen Shugan Huayu decoction. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41080785 | PubMed |
| 41009526 | Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009526 | PubMed |
| 40657372 | Multi-Omics Analysis Reveals the transforming growth factor-β Signaling-Driven Multicellular Interactions with Prognostic Relevance in Cervical Cancer Progression. | J Cancer | 2025 | https://conductscience.org/library/papers/40657372 | PubMed |
| 40624206 | Lovastatin inhibits adipocyte-associated increased proliferation, EMT and aggressiveness of breast cancer cells. | Med Oncol | 2025 | https://conductscience.org/library/papers/40624206 | PubMed |
| 39918251 | Cytokine-centered strategies to boost cancer immunotherapy. | Mol Oncol | 2025 | https://conductscience.org/library/papers/39918251 | PubMed |
| 39917056 | Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39917056 | PubMed |
| 39759107 | The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review. | Open Life Sci | 2024 | https://conductscience.org/library/papers/39759107 | PubMed |
| 39593161 | Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/39593161 | PubMed |
| 39495267 | Study on the mechanism of OSM participating in myocardial fibrosis by inhibiting TGFβ-induced EndMT of cardiac microvascular endothelial cells through SPARC/SMAD signaling. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39495267 | PubMed |
| 39421708 | Evaluation of selected circulating cytokines from the IL-6 family - interleukin 6, oncostatin M, and cardiotrophin-1 - in gastro-entero-pancreatic and bronchial neuroendocrine tumours. | Contemp Oncol (Pozn) | 2024 | https://conductscience.org/library/papers/39421708 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35192545
GET https://conductscience.org/api/papers/v1/35192545/authors?page=2